DMG Productions has selected Lexagene Holdings Inc. to be featured in an upcoming episode of Innovations with Ed Begley Jr. The show will air in the third quarter of 2017 on the Fox Business Network, which is viewed by approximately 85 million households worldwide. As a benefit of being selected, DMG will also produce a 30-second educational commercial spot to air during prime time on networks such as the Discovery Channel, Fox Business, CNN, TLC, Travel Channel, RFD-TV and Food Network.

“Of the thousands of biotech companies out there, to be selected and invited by DMG Productions to participate in Innovations with Ed Begley Jr. is quite an honour. We are very excited to have the opportunity to show the world the features of our technology that separates us from the competition and will enable us to make a positive impact on so many different industries,” said Dr. Jack Regan, Lexagene’s founder and chief executive officer.

Michele Nehls, producer for Innovations, said: “My team is constantly looking at the biotech space for stories that we think are compelling. We ran across Lexagene and were excited to learn that the company is building an open-access platform to bring automated diagnostic to fields that are currently not being supported by the bigger companies. Their technology has the potential to make a big impact on food safety, veterinary diagnostics and even pandemic prevention; and we think the general public will enjoy learning about this company and the technological advances they are making.”

About Lexagene Holdings Inc.

Lexagene is a biotechnology company developing the very first fully automated pathogen detection platform that is open access. The open-access feature will empower end-users to target any pathogen of interest as they can load their own real-time polymerase chain reaction assays onto the instrument for customized pathogen detection.

We seek Safe Harbor.